News
A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...
Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...
GlaxoSmithKline Pharmaceuticals, with its shares currently priced at Rs 3,292.30, remains a key stock to watch, particularly ...
Built on the premise that only 30 per cent of workplace teams are considered high performing is tough to hear!
Business growth consultancy, 24HR Business Plan (24HRBP), has unveiled its newest offering: the 24 Hour High Performance ...
Business Plan has introduced a data-driven coaching program to help leadership teams improve performance.The ...
MANILA, Philippines — Watsons Philippines gathered the brilliant names in the health, wellness and beauty industry for its ...
During a live event, Hari Deshpande, MD, and participants discussed the DeFi trial and the management of nirogacestat in ...
Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...
13h
Stockhead on MSNDr Boreham’s Crucible: Sizing up the opportunity for ASX biotech AdheriumPlenty folk have an asthma puffer but few seem to know how to use it. Adherium says its Hailie device is improving compliance ...
Therapeutics Market is projected to be valued at USD 962.4 million in 2025, reaching USD 1,523.4 million by 2035, with a compound annual growth rate (CAGR) of 4.7% during the forecast period. The ...
The targeted therapy can stop myeloma from progressing by nearly three times as long as existing treatments, studies suggest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results